ClinicalTrials.Veeva

Menu

Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease

I

I.M. Sechenov First Moscow State Medical University

Status

Completed

Conditions

Coronary Artery Disease
NSTEMI - Non-ST Segment Elevation MI
Angina, Stable
Acute Kidney Injury
Angina, Unstable
STEMI - ST Elevation Myocardial Infarction
Contrast-induced Nephropathy

Treatments

Other: Iodinated contrast

Study type

Observational

Funder types

Other

Identifiers

NCT04163484
11/2019

Details and patient eligibility

About

The goal of the study is to assess the prevalence of contrast-associated acute kidney injury in patients with stable coronary artery disease, ST-elevation myocardial infarction and unstable angina/NSTEMI, assess the risk factors of contrast-induced acute kidney injury development and the influence of contrast-induced kidney injury on 1-year prognosis.

Enrollment

156 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Males and females aged 18-80
  • Stable CAD receiving optimal medical treatment requiring PCI or STEMI or NSTEMI
  • Intra-arterial injection of iodinated contrast media
  • Informed consent

Exclusion criteria

  • Age less than 18
  • Pregnancy, lactation
  • Refuse to sign the informed consent
  • Contraindications for PCI
  • Other conditions affecting prognosis (oncology, liver failure etc)
  • CKD stage 4-5
  • Patients receiving nephrotoxic drugs

Trial design

156 participants in 3 patient groups

Stable coronary artery disease
Treatment:
Other: Iodinated contrast
ST-elevation myocardial infarction
Treatment:
Other: Iodinated contrast
Non-ST-elevation myocardial infarction
Treatment:
Other: Iodinated contrast

Trial contacts and locations

1

Loading...

Central trial contact

Vladimir Kuznetsov, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems